Literature DB >> 23404201

Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids.

Minna J Kohler1, Matxalen Amezaga, James Drozd, Susan T Crowley, Barbara Gulanski, Daren R Anderson, Liana Fraenkel.   

Abstract

BACKGROUND: American College of Rheumatology guidelines recommend that patients taking glucocorticoids also take calcium and vitamin D supplements, regardless of the dose or intended duration of glucocorticoid use, to decrease their risk of glucocorticoid-induced osteopenia or osteoporosis (GIOP).
OBJECTIVE: To increase the number of prescriptions made for calcium and vitamin D in patients who receive a prescription for glucocorticoids using an automated, computerized order set.
DESIGN: Pre-post test design. PATIENTS: A total of 1,041 outpatients receiving care at a single VA medical center. INTERVENTION/MAIN MEASURES: We developed an automated order set in which calcium and vitamin D were automatically co-ordered with glucocorticoid prescriptions of at least 2-week duration. We tested the impact of the order set by comparing the number of calcium and vitamin D prescriptions in patients taking glucocorticoids during a 12-month period before (T1) and after (T2) implementation. The automated order set could be modified by the treating physician, and it was not generated for patients with hypercalcemia. KEY
RESULTS: A total of 535 patients during T1 and 506 patients during T2 had a glucocorticoid prescription of at least 2-week duration. The percent of co-prescriptions for calcium increased from 37 to 49% and vitamin D from 38 to 53% (both p < 0.0001) after the new automated order set was implemented.
CONCLUSIONS: Implementation of an automatic prescription for calcium and vitamin D supplementation modestly increases the number of patients on glucocorticoids who are prescribed calcium and vitamin D supplementation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404201      PMCID: PMC3663954          DOI: 10.1007/s11606-013-2360-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  20 in total

1.  Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.

Authors:  Mark Naunton; Gregory M Peterson; Graeme Jones; Gillian M Griffin; Martin D Bleasel
Journal:  J Rheumatol       Date:  2004-03       Impact factor: 4.666

2.  Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.

Authors:  Jeffrey R Curtis; Andrew O Westfall; Jeroan Allison; Angela Becker; Mary Elkins Melton; Allison Freeman; Catarina I Kiefe; Marilyn MacArthur; Theresa Ockershausen; Emily Stewart; Norm Weissman; Kenneth G Saag
Journal:  Arch Intern Med       Date:  2007-03-26

Review 3.  The science and therapy of glucocorticoid-induced bone loss.

Authors:  N E Lane; B Lukert
Journal:  Endocrinol Metab Clin North Am       Date:  1998-06       Impact factor: 4.741

4.  Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.

Authors:  Daniel H Solomon; Jeffrey N Katz; Jonathan P Jacobs; Alison M La Tourette; Jonathan Coblyn
Journal:  Arthritis Rheum       Date:  2002-12

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.

Authors:  T P van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

Review 7.  The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials.

Authors:  K Ann McKibbon; Cynthia Lokker; Steven M Handler; Lisa R Dolovich; Anne M Holbrook; Daria O'Reilly; Robyn Tamblyn; Brian J Hemens; Runki Basu; Sue Troyan; Pavel S Roshanov
Journal:  J Am Med Inform Assoc       Date:  2011-08-18       Impact factor: 4.497

8.  Barriers in the management of glucocorticoid-induced osteoporosis.

Authors:  Jenice Ria S Guzman-Clark; Meika A Fang; Mary E Sehl; Laural Traylor; Theodore J Hahn
Journal:  Arthritis Rheum       Date:  2007-02-15

9.  Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: methods of a decision-maker-researcher partnership systematic review.

Authors:  R Brian Haynes; Nancy L Wilczynski
Journal:  Implement Sci       Date:  2010-02-05       Impact factor: 7.327

10.  Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Authors:  T R Dykman; K M Haralson; O S Gluck; W A Murphy; S L Teitelbaum; T J Hahn; B H Hahn
Journal:  Arthritis Rheum       Date:  1984-12
View more
  5 in total

1.  General internal medicine as an engine of innovation.

Authors:  Richard L Kravitz; Mitchell D Feldman
Journal:  J Gen Intern Med       Date:  2013-06       Impact factor: 5.128

2.  Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.

Authors:  Gherardo Mazziotti; Anna Maria Formenti; Robert A Adler; John P Bilezikian; Ashley Grossman; Emilia Sbardella; Salvatore Minisola; Andrea Giustina
Journal:  Endocrine       Date:  2016-10-20       Impact factor: 3.633

3.  Effectiveness of Evidence-Based Congestive Heart Failure (CHF) CPOE Order Sets Measured by Health Outcomes.

Authors:  Jacob Krive; Joel S Shoolin; Steven D Zink
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

Review 4.  Leveraging the electronic health record to improve quality and safety in rheumatology.

Authors:  Gabriela Schmajuk; Jinoos Yazdany
Journal:  Rheumatol Int       Date:  2017-08-29       Impact factor: 2.631

5.  Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate.

Authors:  Gabriela Schmajuk; Chris Tonner; Yinghui Miao; Jinoos Yazdany; Jacqueline Gannon; W John Boscardin; David I Daikh; Michael A Steinman
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.